MFN Partners’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,400,101
Closed -$236M 14
2019
Q3
$236M Buy
1,400,101
+500,000
+56% +$81.5M 35.22% 1
2019
Q2
$151M Buy
900,101
+250,000
+38% +$34.6M 23.92% 1
2019
Q1
$95.2M Hold
650,101
15.35% 1
2018
Q4
$86.9M Buy
+650,101
New +$107M 14.74% 2

Other funds holding AGN

MFN Partners's AGN Position: Q4 2019 in Review

MFN Partners sold out of Allergan plc (AGN) in Q4 2019, closing a stake of 1,400,101 shares — an estimated $236M sold.

MFN Partners first reported a position in AGN in Q4 2018 and held it in 4 quarters. The position peaked at $236M in Q3 2019. 957 funds tracked by Wall St. Rank hold AGN as of Q4 2019.

  • MFN Partners reported no remaining Allergan plc position as of Q4 2019 after selling out during the quarter.
  • MFN Partners sold 1,400,101 Allergan plc shares in Q4 2019, an estimated $236M.
  • MFN Partners first reported a position in Allergan plc in Q4 2018 and held it in 4 quarters.
  • MFN Partners's Allergan plc position peaked at $236M in Q3 2019.
  • 957 funds tracked by Wall St. Rank held Allergan plc as of Q4 2019.

Based on MFN Partners's 13F filing for Q4 2019, filed 13 Feb 2020.